Switching from other types of basal insulin (detemir and glargine) to insulin degludec showed a high level of glycemic control and significant lowering of overall and nocturnal hypoglycemia in type 1 and type 2 DM in a one-year observational study [18]. The gene discussed is INS; the disease is Hypoglycemia.